Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Peer-reviewed

Research Article

Characterisation of K+ Channels in Human Fetoplacental Vascular Smooth Muscle Cells

  • Melissa F. Brereton ,

    melissa.brereton@dpag.ox.ac.uk

    Current address: Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, United Kingdom

    Affiliation Maternal and Fetal Health Research Centre, Institute of Human Development, University of Manchester, Manchester Academic Health Sciences Centre (MAHSC), St, Mary's Hospital, Manchester, United Kingdom

    ⨯
  • Mark Wareing,

    Affiliation Maternal and Fetal Health Research Centre, Institute of Human Development, University of Manchester, Manchester Academic Health Sciences Centre (MAHSC), St, Mary's Hospital, Manchester, United Kingdom

    ⨯
  • Rebecca L. Jones,

    Affiliation Maternal and Fetal Health Research Centre, Institute of Human Development, University of Manchester, Manchester Academic Health Sciences Centre (MAHSC), St, Mary's Hospital, Manchester, United Kingdom

    ⨯
  • Susan L. Greenwood

    Affiliation Maternal and Fetal Health Research Centre, Institute of Human Development, University of Manchester, Manchester Academic Health Sciences Centre (MAHSC), St, Mary's Hospital, Manchester, United Kingdom

    ⨯

Abstract

Adequate blood flow through placental chorionic plate resistance arteries (CPAs) is necessary for oxygen and nutrient transfer to the fetus and a successful pregnancy. In non-placental vascular smooth muscle cells (SMCs), K+ channels regulate contraction, vascular tone and blood flow. Previous studies showed that K+ channel modulators alter CPA tone, but did not distinguish between effects on K+ channels in endothelial cells and SMCs. In this study, we developed a preparation of freshly isolated CPASMCs of normal pregnancy and investigated K+ channel expression and function. CPASMCs were isolated from normal human term placentas using enzymatic digestion. Purity and phenotype was confirmed with immunocytochemistry. Whole-cell patch clamp was used to assess K+ channel currents, and mRNA and protein expression was determined in intact CPAs and isolated SMCs with RT-PCR and immunostaining. Isolated SMCs expressed α-actin but not CD31, a marker of endothelial cells. CPASMCs and intact CPAs expressed h-caldesmon and non-muscle myosin heavy chain-2; phenotypic markers of contractile and synthetic SMCs respectively. Whole-cell currents were inhibited by 4-AP, TEA, charybdotoxin and iberiotoxin implicating functional Kv and BKCa channels. 1-EBIO enhanced whole cell currents which were abolished by TRAM-34 and reduced by apamin indicating activation of IKCa and SKCa respectively. BKCa, IKCa and SKCa3 mRNA and/or protein were expressed in CPASMCs and intact CPAs. This study provides the first direct evidence for functional Kv, BKCa, IKCa and SKCa channels in CPASMCs. These cells display a mixed phenotype implicating a dual role for CPASMCs in controlling both fetoplacental vascular resistance and vasculogenesis.

Citation: Brereton MF, Wareing M, Jones RL, Greenwood SL (2013) Characterisation of K+ Channels in Human Fetoplacental Vascular Smooth Muscle Cells. PLoS ONE 8(2): e57451. https://doi.org/10.1371/journal.pone.0057451

Editor: Alexander G. Obukhov, Indiana University School of Medicine, United States of America

Received: September 20, 2012; Accepted: January 24, 2013; Published: February 21, 2013

Copyright: © 2013 Brereton et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Funding: This work was supported by University of Manchester 2008–2012 Medical Research Council Doctoral Training Grant (G0800127), Tommy's the baby charity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing interests: The authors have declared that no competing interests exist.

Introduction

Appropriate control of human placental blood flow is necessary for maximal exchange of oxygen and nutrients to the growing fetus and a successful pregnancy. Placental chorionic plate arteries (CPAs) branch from the umbilical arteries and are likely the primary determinants of fetoplacental vascular resistance as they have similar size characteristics (<500 µm) to systemic resistance vessels [1]. Fetoplacental vascular resistance falls across gestation, indicated clinically by umbilical artery Doppler waveform analysis. Fetoplacental blood vessels lack innervation and respond poorly to potent vasoactive agents of the systemic circulation [1], [2]. The primary mechanism to elicit vasodilation and maintain low vascular resistance throughout gestation is flow-induced nitric oxide (NO) release [3]. A high flow/low resistance circulation is essential to promote sufficient maternal-fetal exchange of oxygen and nutrients. Appropriate regulation of SMC function, and therefore fetoplacental vascular tone and blood flow, is necessary to facilitate maximal exchange of these substances and thereby support fetal growth. However, CPA smooth muscle cell (CPASMC) excitation-contraction coupling is poorly understood and studies are currently hindered by the lack of a suitable single cell model of isolated CPASMCs.

In non-placental vascular SMCs, potassium (K+) channels are important in controlling excitation-contraction coupling [4]. K+ channels are important determinants of the resting membrane potential in vascular SMCs and are regulated by circulating vasoconstrictors and vasodilators. Membrane depolarisation, resulting from K+ channel closure, provides the trigger for opening of voltage-gated Ca2+ channels and the subsequent Ca2+ influx to promote vasoconstriction [5]. Conversely, K+ efflux due to K+ channel openings causes membrane hyperpolarisation and therefore vasodilation. Non-placental VSMCs express members from all four K+ channel families; Kv, KIR, K2P and KCa [4].

A small number of studies have indirectly assessed the role of K+ channels in CPASMC excitation-contraction coupling in normal pregnancy. Using a range of K+ channel modulators in the in vitro perfused placenta and isolated CPAs, Kv, KATP, K2P and KCa channels have been implicated in regulating basal and agonist-induced tone [6], [7], [8], [9], [10], [11], [12]. K+ channels have also been implicated in the maintenance of the resting membrane potential of CPASMCs around −38 mV and its sensitivity to high external K+ [13]. Membrane depolarisation and hyperpolarisation elicited by serotonin (5-HT) and acetylcholine (ACh) respectively, was modulated by charbydotoxin and glibenclamide suggesting the presence of KCa and KATP channel conductances in CPASMCs [14]. Previous expression studies demonstrate mRNA and protein for BKCa and some Kv isoforms in whole placental homogenate or intact CPAs [8], [10], [11], [15]. However, functional studies of CPA constriction or relaxation with channel modulators have not distinguished between effects on K+ channels expressed in endothelial cells and smooth muscle cells. The ion channel physiology of SMCs from resistance CPAs has yet to be investigated directly.

In this study, we developed a preparation of freshly isolated SMCs from CPAs of normal pregnancy and characterised K+ channel currents, mRNA and protein expression using whole-cell electrophysiology, immunocytochemistry and RT-PCR.

Methods

Ethical Approval

This work was performed with ethical approval from the North West (Haydock Park) Research Ethics Committee (Ref: 08/H1010/55) and informed written consent obtained for all collected tissue. Term placentas (37–42 weeks gestation; N = 40) were collected within 30 min of delivery (vaginal delivery or elective caesarean section) from women with uncomplicated pregnancies (no evidence of hypertension, FGR or other medical disorders). The investigation conforms to the principles outlined in the Declaration of Helsinki.

Isolation of chorionic plate arterial smooth muscle cells

Small (150–500 µm internal diameter) CPAs were dissected from placental biopsies using fine dissecting forceps. CPAs were cut into 5 mm lengths and maintained in Ca2+ free-dissociation media (DM containing in mM: 120 NaCl, 25 NaHCO3, 4.2 KCl, 0.6 KH2PO4, 1.2 MgCl2, 11 Glucose; pH 7.4 for 5 min). CPAs were transferred into a tube containing 1 ml DM containing papain, and DTT (both 1.0 mg/ml) for 20 min at 37°C. The tissue was washed three times in ice-cold Ca2+ free-DM and transferred to 0.01 mM Ca2+-DM containing; collagenase type 1A and collagenase type F (both 1.0 mg/ml) and incubated at 37°C for 10 min. The vessels were washed three times in ice-cold 0.01 mM Ca2+-DM and triturated with a fire-polished glass Pasteur pipette.

Characterisation of chorionic plate arterial smooth muscle cells

Immunocytochemistry was performed on the cell isolates following methanol fixation to determine; (1) the purity of the isolation technique using SMC markers α-smooth muscle actin (α-SMA; 15 µg/ml; A2547 Sigma-Aldrich), myosin-heavy chain-2 (MHC-2; 1∶250; ab683 Abcam), and the endothelial cell marker CD31 (5 µg/ml; M0823 DAKO), (2) SMC phenotype using the contractile marker h-caldesmon (7.7 µg/ml; C4562 Sigma-Aldrich) and synthetic marker non-muscle myosin heavy chain-B (NMMHC-B; 1∶1000; ab684 Abcam). Endogenous peroxidase activity was quenched with 3% H2O2 for 10 min. Non-specific binding was prevented by incubation for 30 min with non-immune block (10% goat serum, 2% human serum, and 0.1% Tween 20 in TBS). Primary antibodies were optimised and diluted in non-immune block and incubated overnight at 4°C. Negative controls were performed following substitution of the primary antibody with the corresponding concentration of non-immunised IgG. Antibody binding was detected by application of secondary antibody (biotinylated goat anti-mouse IgG; E0433; DAKO) for 30 min and avidin peroxidase (100 µg/ml in TBS) for a further 30 min. Staining was developed using diaminobenzidine (0.75% solution in TBS) and counterstained with Harris's haematoxylin, dehydrated and then mounted.

SMC marker protein expression was confirmed in intact CPAs. CPA sections were formalin fixed for 24 h, dewaxed, rehydrated, and microwaved for antigen retrieval in 0.01 M sodium citrate (pH 6.0). The subsequent incubation steps were repeated as described above.

Whole-cell K+ current recordings

Spindle-shaped, relaxed SMCs obtained within 4 h of isolation were selected for electrophysiology experiments. Aliquots of the cell suspension (50 µl) were left to settle and attach for 20–30 min before addition of extracellular solution (2 ml). Recordings were made using the whole-cell patch-clamp technique [16]. Haematocrit glass patch pipettes (3–6 MΩ resistance) were pulled using a vertical pipette puller (PC-10, Narishige). Voltage protocols were applied using an Axopatch 200B amplifier (Molecular Devices, Sunnyvale, CA, USA) with pCLAMP 10.2 software (Axon Instruments). Cells were voltage clamped at −60 mV and step depolarised from −70 mV to +80 mV for 500 ms in 10 mV increments and repolarised to −40 mV. Membrane capacitance was calculated using manual whole-cell capacitance controls on the Axopatch amplifier. All recordings were performed at room temperature (22–25°C).

Cells were bathed with extracellular solution containing (mM): 140 NaCl, 5 KCl, 1 CaCl2, 1 MgCl2, 5 HEPES, 10 Mannitol and 5 Glucose (pH 7.3 with NaOH). Patch pipettes were filled with (mM): 120 K-aspartate, 20 KCl, 1 MgCl2, 0.5 EGTA, 35 Mannitol and 5 HEPES (pH 7.2 with KOH). K+ channel function was assessed by extracellular application of 4-aminopyridine (4-AP; Kv inhibitor; 5 mM), tetraethylammonium (TEA; KCa inhibitor; 5 mM), charybdotoxin (ChTx; BKCa and IKCa inhibitor 100 nM), iberiotoxin (IbTx; BKCa inhibitor; 100 nM), TRAM-34 (IKCa inhibitor; 10 µM), apamin (SKCa inhibitor; 100 nM) and 1-EBIO (IKCa opener; 100 µM). Drug concentrations were chosen according to previous electrophysiology experiments performed in non-placental vascular SMCs [17], [18], [19], [20], [21], [22], [23]. All K+ channel modulators were diluted in extracellular solution. Once whole-cell currents had stabilised in control solutions, K+ channel modulators were microinjected into the bath solution and currents allowed to approach a new steady state prior to recording. Poor adhesion of the cell isolates to the recording chamber necessitated the use of a static perfusion system and prevented washout of drugs.

K+ channel protein expression in chorionic plate arterial SMCs

Expression of BKCa (10 µg/ml; APC-107 Alomone Labs) and IKCa (8 µg/ml; APC-064 Alomone Labs) was assessed in CPASMCs by immunocytochemistry and confirmed in CPA sections.

K+ channel mRNA expression in chorionic plate arteries

Total RNA was extracted from CPAs (approximately 3 cm lengths; diameter <500 µm) using the RNeasy® Fibrous Tissue Mini Kit (QIAGEN®, Crawley, UK) according to the manufacturer's instructions, including a DNase incubation step. RNA purity was assessed using spectrophotometric analysis and quantified using a Quant-iT™ Ribogreen® RNA assay kit with reference to rRNA standards (Molecular Probes, Invitrogen). RNA extracted from CPAs isolated from 10 placentas was stored at -80°C. cDNA was generated in duplicate from 25 ng RNA using a Stratagene Affinity Script Multi-temperature cDNA synthesis kit (Agilent, Stockport, UK). Real-time PCR was performed for a housekeeping gene and cDNA pooled if acceptable duplicates using a Stratagene MX3000P system (Agilent) using Brilliant II SYBR® Green Master Mix (Stratagene). Primers used have either been previously been described by our group in chorionic plate arteries; BKCa (F)5'-AAGCAACGGAATGGAGGCAT-3' (R)5'-CCAGTGAAACATCCCAGTAGAGT-3', or obtained from PrimerBank and optimised for use in this system; IKCa (F)5'-GCTGCTGCGTCTCTACCTG-3' (R)5'-AAGCGGACTTGATTGAGAGCG-3'; SKCa3 (F)5'-GGCGGATAGCCATGACCTAC-3' (R)5'-CGTGCCGTCCAGAAGAACTT-3'. BLAST searches were performed to ensure primers had no homology with other known gene products. Cycling parameters were: 1 cycle at 95°C for 10 minutes, 40 cycles at 95°C for 30 s (denature), X°C for 1 min (X denotes the annealing temperature specific for each primer set; BKCa; X = 60, IKCa and SKCa3; X = 61) and 72°C for 1 min (extension). Fluorescence measurements were calculated after each anneal and extension step. A dissociation curve was performed for all PCRs to ensure specificity of the reaction. All PCRs were conducted in duplicate with negative controls on the same plate. cDNA generated from human reference RNA was used as a positive control. PCR products were resolved using 2% agarose gel electrophoresis.

Chemicals and statistical analysis

General chemicals and pharmacological agents were purchased from Sigma-Aldrich, Poole, Dorset, UK including; collagenase type F, collagenase type 1A, DTT (DL-Dithiothreitol), papain, goat serum, avidin peroxidise, Tween-20, 3,3′-Diaminobenzidine tetrahydrochloride hydrate (DAB), Harris's haematoxylin, 4-AP TEA, 1-EBIO and TRAM-34. Swine serum was obtained from Vector Laboratories Inc., Burlingame, CA, USA. Charybdotoxin, iberiotoxin and apamin were purchased from Alomone Labs, Jerusalem, Israel. Whole-cell currents were normalised to cell capacitance and results represented as mean ± S.E.M (n =  no. cells; N =  no. placentas; statistical evaluation was performed using Wilcoxon-matched pairs signed rank test and Two-way ANOVA with n as the number of cells obtained from a minimum of N = 3 placentas). Current-voltage relationships were constructed from currents measured at 490 ms and significance considered at the P<0.05 level.

Results

Characterisation of chorionic plate arterial SMCs

Cell isolates had a long, oval shaped morphology. They displayed positive immunostaining for the SMC markers α-smooth muscle actin (α-SMA; N = 4; Figure 1A) and myosin heavy chain-2 (MHC-2; N = 3; Figure 1C), and an absence of staining for the endothelial cell marker CD31 (N = 3; Figure 1B), confirming that they were SMCs. Consistent with previous studies in CPAs in situ [24], CPASMCs expressed the contractile and synthetic SMC phenotypic markers h-caldesmon (N = 3; Figure 1D) and non-muscle myosin heavy chain-B (NMMHC-B; N = 3; Figure 1E) respectively. Staining for these proteins was variable as cells displayed both positive and negative staining for h-caldesmon and NMMHC-B in the same field of vision (Figure 1 D, E).

thumbnail
Download:
Figure 1. Phenotype characterisation of isolated CPASMCs.

Representative examples of immunocytochemistry (A) α-smooth muscle actin (α-SMA), (B) CD31, (C) myosin heavy chain-2 (MHC-2), (D) h-caldesmon, (E) non-muscle myosin heavy chain-B (NMMHC-B), and (F) negative control; non-immune IgG. Positive immunostaining (DAB; brown) and nuclei (haematoxylin; blue).

https://doi.org/10.1371/journal.pone.0057451.g001

In keeping with isolated SMCs, SMCs of CPA sections expressed proteins that are associated with both contractile, α-SMA (N = 4; Figure 2A), MHC-2 (N = 4; Figure 2C), h-caldesmon (N = 4; Figure 2D) and synthetic NMMHC-B (N = 4; Figure 2E) SMCs. The endothelium was clearly visible with CD31 staining (N-4; Figure 2B). No staining was evident in either CPASMCs (N = 4; Figure 1F) or CPA sections (N = 4; Figure 2F) following substitution of primary antibody with non-immune IgG at an equivalent concentration.

thumbnail
Download:
Figure 2. Phenotype characterisation of CPASMCs.

Representative examples of immunohistochemistry (A) α-smooth muscle actin (α-SMA), (B) CD31 (C) myosin-heavy chain-2 (MHC-2) (D) h-caldesmon, (E) non-muscle myosin heavy chain-B (NMMHC-B), and (F) negative control; non-immune IgG. Positive immunostaining (DAB; brown) and nuclei (haematoxylin; blue). SMC; smooth muscle cell, L; lumen.

https://doi.org/10.1371/journal.pone.0057451.g002

Characterisation of passive membrane properties and whole-cell current profiles

Membrane capacitance of CPASMCs ranged from 11.0 pF to 41.8 pF (23.2±7.6 pF; mean±SEM; n = 66; N = 24). Step depolarisation from a holding potential of −60 mV to a series of test potentials between −70 mV and +80 mV elicited outward currents with a threshold potential of activation between −40 mV and −10 mV. In the majority of cells (56/66; 85%), currents displayed time-dependent activation, were outwardly rectifying and current magnitude fluctuated at depolarised potentials (e.g. Figure 3A) characteristic of transient openings of BKCa channels described in SMCs of several vascular beds [17], [18], [19], [20], [21], [25]. These currents were superimposed upon a smaller, time-independent current. In 15% of cells; the smaller current was only recorded under basal conditions. The number of voltage steps displaying fluctuating currents, their magnitude and time course was variable between cells and did not correlate with any apparent visual differences in cell morphology under a light microscope.

thumbnail
Download:
Figure 3. Characterisation of functional voltage-gated (Kv) and Ca2+-activated K+ channels (KCa) in CPASMCs.

Representative example of the inhibition of outward currents in CPASMCs at negative membrane potentials by the Kv blocker 4-aminopyridine (4-AP; 5 mM; A) and at depolarised potentials following co-application of the KCa inhibitor tetraethylammonium (TEA; 5 mM; A). Mean current-voltage relationships measured at the end of the 500 ms voltage step ranging from −70 mV to +80 mV were obtained in the absence (•) and presence (○) of 4-AP (B; n = 11, N = 8) and TEA alone (D; n = 11, N = 6). * indicates currents (mean ± SEM) P<0.05; Two-way ANOVA followed by Bonferroni Post Hoc Test. 4-AP (C) and TEA (E) sensitive currents were linear and outwardly rectifying respectively.

https://doi.org/10.1371/journal.pone.0057451.g003

K+ channel currents in chorionic plate arterial SMCs

To identify K+ channels that may contribute to whole-cell currents in CPASMCs, a pharmacological approach was employed.

The broad-spectrum Kv channel blocker 4-AP (5 mM), had a small but significant inhibitory effect on the small time-independent current at potentials between 0 mV and +40 mV (at +40 mV: control 4.7± 0.8 pA/pF; 4-AP 2.9±0.4 pA/pF; P<0.05; Wilcoxon matched-pairs signed rank test; n = 11, N = 8; Figure 3A). Current-voltage relationships measured at the end of the 500 ms voltage step were obtained in the absence (•) and presence (○) of 5 mM 4-AP with significant inhibition of currents evident at +30 mM and +40 mV, and potentials depolarised to +70 mV (P<0.05; Two-way ANOVA followed by Bonferroni Post Hoc Test; Figure 3B). 4-AP sensitive current reversed close to the K+ equilibrium potential implicating the presence of Kv channel current (Figure 3C). The majority of the outward currents were not affected by 4-AP.

Application of the broad-spectrum KCa blocker TEA (5 mM) abolished the majority of outward currents in CPASMCs that were insensitive to 4-AP (Figure 3A). TEA preferentially inhibited at potentials positive to +50 mV, with a 66±5% decrease observed at +80 mV (n = 11; N = 6). Current-voltage relationships measured at the end of the 500 ms voltage step were obtained in the absence (•) and presence (○) of TEA alone with significant inhibition of currents evident at potentials depolarised to +60 mV (P<0.05; Two-way-ANOVA followed by Bonferroni Post Hoc Test Figure 3D). TEA-sensitive currents were outwardly rectifying and reversed close to the K+ equilibrium potential indicating KCa channel currents (Figure 3E).

Identifying the specific KCa isoform responsible for CPASMC currents utilised application of pharmacological blockers. Inhibition of BKCa and IKCa isoforms with ChTx abolished outward currents (n = 4; N = 2; Figure 4A). Selective blockade of IKCa channels with TRAM-34 was without effect on outward currents (n = 3, N = 2; Figure 4B). Conversely, inhibition of BKCa channels with IbTx abolished outward currents at +80 mV by 61±12% (n = 10, N = 4; Figure 4C), in common with TEA (Figure 3) and ChTx (Figure 4A). Current-voltage relationships measured at the end of the 500 ms voltage step were obtained in the absence (•) and presence (○) of IbTx with significant inhibition evident at potentials depolarised to +70 mV (P<0.05; Two-way-ANOVA followed by Bonferroni Post Hoc Test; (Figure 4D). IbTx-sensitive currents were outwardly rectifying and reversed close to the K+ equilibrium potential indicating that they were mediated by BKCa channels (Figure 4E).

thumbnail
Download:
Figure 4. Characterisation of Ca2+-activated K+ channel isoforms in CPASMCs.

Representative example of the inhibition of outward currents by the BKCa and IKCa blocker charybdotoxin (ChTx; n = 4; N = 2; 100 nM; A), but not the specific IKCa inhibitor TRAM-34 (n = 3, N = 2; 10µM; B). The specific BKCa blocker iberiotoxin (IbTx; 100 nM; C) inhibited outward currents at depolarised potentials. Mean current-voltage relationships measured at the end of the 500 ms voltage step ranging from -70 mV to +80 mV were obtained in the absence (•) and presence (○) of IbTx (D; *P<0.05; Two-way ANOVA followed by Bonferroni Post Hoc Test; mean ± SEM; n = 8, N = 4). IbTx-sensitive currents (E) were outwardly rectifying.

https://doi.org/10.1371/journal.pone.0057451.g004

Further analysis of the contribution of KCa channels to whole-cell currents was performed with extracellular application of 1-EBIO (IKCa and SKCa channel activator). 1-EBIO increased whole-cell currents in all cells tested (control: 6.6±2.1 pA/pF; 1-EBIO: 29.1±6.9 pA/pF at +80 mV; P<0.05; n = 22, N = 10; Wilcoxon matched-pairs signed rank test; Figure 5A). Current-voltage relationships measured at the end of the 500 ms voltage step were obtained in the absence (•) and presence (○) of 1-EBIO with significant activation evident at potentials depolarised to +60 mV (P<0.05; Two-way-ANOVA followed by Bonferroni Post Hoc Test; Figure 5B). Tail-currents were observed in 2 out of 22 recordings following 1-EBIO application (see Figure 5A) characteristic of Kv channels. However, the low incidence of these currents prevented further analysis. Abolition of the 1-EBIO response with TEA confirmed this increase in whole-cell current was mediated by a KCa channel (Figure 5A). Experiments to determine the KCa isoform responsible for 1-EBIO-sensitive current excluded a role for BKCa as selective blockade of these channels with IbTx in the continued presence of 1-EBIO, had no effect on the magnitude of outward currents (1-EBIO: 15.2±11.2 pA/pF; 1-EBIO + IbTx: 14.2±9 pA/pF at +80 mV; P>0.05; Wilcoxon matched-pairs signed rank test; n = 3, N = 3; Figure 5C).

thumbnail
Download:
Figure 5. Characterisation of Ca2+-activated K+ channel openers in CPASMCs.

The IKCa and SKCa channel activator 1-EBIO (100 µM) increased outwards currents in CPASMCs (A). Mean current-voltage relationships obtained at the end of the 500 ms voltage step in the absence (•) and presence (○) of 1-EBIO (B; *P<0.05; Two-way ANOVA followed by Bonferroni Post Hoc Test; mean ± SEM; n = 22; N = 10). The 1-EBIO sensitive current was inhibited by the KCa inhibitor TEA (A; 5 mM; n = 2; N = 2), but not the specific BKCa inhibitor iberiotoxin (IbTx; 100 nM; C).

https://doi.org/10.1371/journal.pone.0057451.g005

Selective inhibition of IKCa isoforms with TRAM-34 (n = 7, N = 4) reduced 1-EBIO sensitive currents (1-EBIO: 34.5±10.0 pA/pF; 1-EBIO + TRAM-34: 7.1±2.7 pA/pF at +80 mV; P<0.05; Wilcoxon matched-pairs signed rank test; n = 7, N = 4; Figure 6A). Current-voltage relationships measured at the end of the 500 ms voltage step were obtained in the absence (•) and presence of 1-EBIO (○) and presence of 1-EBIO with TRAM-34 (x). Addition of TRAM-34 following 1-EBIO application restored the current voltage relationship to the basal level (Figure 6B). In addition, inhibition of SKCa isoforms with apamin reduced 1-EBIO sensitive currents (+80 mV from 17.5±5.0 pA/pF to 10.7±2.4 pA/pF; P<0.05; Wilcoxon matched-pairs signed rank test; n = 7; N = 3 Figure 6C). The remaining currents were blocked by TRAM-34. Current-voltage relationships measured at the end of the 500 ms voltage step were obtained in the absence (•) and presence of 1-EBIO (○) and presence of 1-EBIO with apamin (x) (Figure 6D).

thumbnail
Download:
Figure 6. Functional intermediate-conductance (IKCa) and small-conductance (SKCa) Ca2+-activated K+ channels in CPASMCs.

The specific IKCa inhibitor TRAM-34 (10 µM) abolished 1-EBIO sensitive currents (A). Mean current-voltage relationships obtained at the end of the 500 ms voltage step under control conditions (•), and following application of 1-EBIO (○) and TRAM-34 in the continued presence of 1-EBIO (x) (mean±SEM; n = 7; N = 4; B). The specific SKCa inhibitor apamin (100 nM) partially inhibited 1-EBIO sensitive currents and the remaining current was abolished by the subsequent addition of TRAM-34 (C). Mean current-voltage relationships obtained at the end of the 500 ms voltage step under control conditions (•), and following application of 1-EBIO (○) and apamin in the continued presence of 1-EBIO (x) (mean±SEM; n = 7; N = 3; D).

https://doi.org/10.1371/journal.pone.0057451.g006

KCa channel expression in chorionic plate arteries

Protein expression of the pore-forming α-subunits of BKCa and IKCa was evident in isolated CPASMCs (N = 3; Figure 7A, B) and intact CPA sections (N = 3; Figure 7D, E). Non-specific staining in either isolated SMCs (N = 4; Figure 7C) or CPA sections (N = 4; Figure 7F) was not observed following substitution of primary antibody with non-immune IgG at an equivalent concentration. mRNA for BKCa (Figure 7G, 32 ± 1; CT values median ± IQR), IKCa channels (Figure 7H, 35±2; CT values median ± IQR) and SKCa3 (Figure 7I, 33±2; CT values median ± IQR) was also expressed in intact CPA sections.

thumbnail
Download:
Figure 7. mRNA and protein expression of KCa channels in CPAs.

Isolated CPASMCs expressed BKCa (A) and IKCa (B) protein. BKCa (D) and IKCa (E) protein was localised to the SMCs in intact CPA sections. Negative control (C) and (F); substitution of primary antibody with non-immune IgG. RT-PCR detection of BKCa (G) IKCa (H) and SKCa3 (I) transcripts in human reference cDNA (Std), chorionic plate artery (CPA). Negative (Neg) is omission of cDNA. Amplicon lengths; BKCa 147, IKCa 102 and SKCa3 106. SMC; smooth muscle cell, L; lumen.

https://doi.org/10.1371/journal.pone.0057451.g007

Discussion

Currently, no studies have systematically investigated K+ channel activity in SMCs of resistance arteries in the human placenta that regulate fetoplacental blood flow. In this study, a method was developed to isolate SMCs from placental chorionic plate arteries with size characteristics of resistance vessels for whole cell recording to characterise K+ currents. We showed that the cells express several K+ currents that, on the basis of their pharmacology, could be attributed to Kv, BKCa, IKCa, and SKCa channels. The contribution of these channels was supported by their mRNA and/or protein expression in intact arteries and in SMCs after isolation.

The isolation protocol produced a high yield of relaxed CPASMCs, which displayed positive immunostaining for SMC markers and negative staining for an endothelial cell marker. Phenotypic characterisation of CPASMCs confirmed our previous electron microscopy studies of the native artery [24]; isolated CPASMCs and intact CPAs displayed a mixed phenotype, expressing markers of both contractile (h-caldesmon) and synthetic (NMMHC-B) SMC phenotypes. The h-caldesmon and NMMHC-B staining intensity was variable between the isolates suggesting a range of intermediate phenotypes between purely contractile and synthetic. The presence of synthetic SMCs in CPAs, which are important in controlling vasculogenesis, is consistent with the fetal origin of the tissue [26]. A high incidence of synthetic relative to contractile SMCs will impact upon the response of CPAs to modulators of vascular tone and may explain why these vessels are relatively unresponsive to potent vasoactive agents of the systemic circulation [1].

The major K+ currents expressed in CPASMCs under basal conditions were investigated. Whole-cell currents comprised a linear, time-independent component and an outwardly rectifying component characterised by the presence of fluctuating currents at depolarised potentials. Current magnitude was variable between cells and was not related to cell size or obvious differences in cell morphology; only relaxed SMCs with a defined membrane were used for electrophysiology experiments. Variability in the current profiles could relate to their phenotype (i.e. synthetic/contractile). However, linking current profiles to SMC phenotype necessitates staining cells that have been recorded which was beyond the scope of this initial investigation to screen K+ currents in CPASMCs for the first time.

A pharmacological approach was employed to identify the K+ channels responsible for outward currents in CPASMCs. Voltage-gated K+ channels (Kv) were initially targeted given the previous expression and functional data demonstrating a role for these channels in modulating basal and agonist-induced tone in the perfused placenta and isolated CPAs using the Kv channel blocker 4-AP [8], [10], [11]. In CPASMCs, 4-AP inhibited currents at relatively negative membrane potentials. This suggests Kv channels may be important at physiological membrane potentials and is consistent with 4-AP enhancing basal tone in the intact vessel [8]. The precise Kv channel isoforms responsible for 4-AP sensitive currents in CPASMCs remains unknown but previous studies have demonstrated Kv1.5 [27], Kv7.4 [28] and Kv9.3 [29] protein expression in the SMCs of intact CPA sections. Microelectrode impalement studies have demonstrated that the membrane potential of CPASMCs in the intact vessel is approximately −38 mV and is sensitive to high external K+ [13]. Membrane depolarisation and hyperpolarisation elicited by serotonin (5-HT) and acetylcholine (ACh) respectively, was modulated by ChTx and glibenclamide suggesting the presence of KCa and KATP conductances in CPASMCs [14]. However, it remains to be determined in isolated CPASMCs, whether Kv channels per se and specifically which isoforms contribute to maintaining the resting membrane potential and are therefore directly responsible for 4-AP induced alterations in basal tone.

Ca2+-activated K+ channels were next targeted given previous studies demonstrating a role for these channels in modulating fetoplacental vascular tone [8], [10], [11]. The marked inhibition by TEA (KCa inhibitor), charybdotoxin (BKCa and IKCa inhibitor), iberiotoxin (BKCa inhibitor) but not TRAM-34 (IKCa inhibitor) suggests that BKCa channels are responsible for the majority of outward currents in CPASMCs under the recording condition used in the present study. Expression of BKCa mRNA and protein was confirmed in CPAs and protein localised to the SMCs. In common with non-placental vascular SMCs [17], [18], [19], [20], [21], the large single-channel conductance of BKCa likely accounts for the characteristic noise and fluctuating currents observed at depolarised potentials in CPASMCs. BKCa activity in the present study likely reflects membrane depolarisation induced Ca2+ entry given the low intracellular Ca2+ recording concentrations employed (0.5 mM [EGTA]i; predicted [Ca2+]i ∼10 nM). Compared to pulmonary resistance arterial SMCs which similarly carry deoxygenated blood but express primarily Kv channels, the predominance of KCa over Kv channels in CPASMCs is interesting. Extrapolation of this in vitro finding to the physiological situation in the intact vessel or whole placenta where there is a complex ionic environment should be made with caution. However, together with previous observations demonstrating functional BKCa channels in the whole-perfused placenta, intact artery and large diameter CPASMCs using iberiotoxin and charybdotoxin [8], [10], [11], this study implicates a role for BKCa channels in CPASMC excitation-contraction coupling.

Further analysis of the role of KCa channels in CPASMCs demonstrated IKCa currents. Application of the SKCa and IKCa activator 1-EB1O significantly increased outward currents. 1-EBIO sensitive currents were reduced by TEA (KCa inhibitor), TRAM-34 (IKCa inhibitor), but unaffected by the BKCa inhibitor iberiotoxin indicating functional IKCa channels. In non-placental blood vessels, immunohistochemical and electrophysiological studies do not implicate IKCa channel expression or function in SMCs, rather, they are localised to the endothelium [23], [30], [31], [32], [33]. Electrophysiology experiments in SMCs isolated from the rat hepatic artery [32] and mouse portal vein [23] failed to observe an effect of 1-EBIO on whole-cell K+ currents. This is in marked contrast to CPASMCs where 1-EBIO consistently increased currents at +80 mV by over 400%. The effect of 1-EBIO is strongly Ca2+ dependent [34] and stimulation of IKCa usually requires high intracellular Ca2+ concentrations or addition of the Ca2+ ionophore ionomycin. Why 1-EBIO is causing significant current activation in CPASMCs given the low recording intracellular Ca2+ concentration in this study is unclear. Similarly, the apparent time-dependent activation of the 1-EBIO-sensitive current is inconsistent with the voltage-independent nature of IKCa channels. However, 1-EBIO-sensitive currents will be modulated by other underlying ion conductances native to these cells. In addition, kinetic analyses were not performed to quantify differences in current profiles following 1-EBIO application given the inherent variability in outward currents recorded. The data demonstrating abolition of 1-EBIO-activated currents with TRAM-34, together with those demonstrating IKCa mRNA and protein expression, provides strong evidence for the presence of IKCa channels in CPAs and their localisation to SMCs.

1-EBIO can also activate SKCa channels. It was therefore investigated whether the SKCa inhibitor apamin had any effect on 1-EBIO sensitive currents. Application of apamin at a concentration that inhibits both SKCa isoforms [35] reduced 1-EBIO sensitive currents but to a lesser extent than TRAM-34. In common with IKCa channels, SKCa are thought to predominantly localise to the endothelium where they participate in the EDHF response [30], [36]. Therefore, functional SKCa channels in CPASMCs were unexpected and may be mediated by the SKCa3 isoform given mRNA expression for the pore forming α-subunit in the intact artery. Protein expression of SKCa3 remains to be determined in the intact CPA and CPASMCs. The functional significance of SKCa3 channels in CPASMCs is not known but they may be important in dampening excitation and promoting vasodilation following a rise in intracellular Ca2+ in common with BKCa channels.

It is evident that CPASMCs are a heterogeneous population of cells; they express diverse K+ channel currents with varying magnitude and activation profiles, and display a mixed phenotype with both contractile and synthetic characteristics. In other vascular SMCs, a close relationship exists between phenotype and K+ channel expression [37], [38], [39]. SMCs with a contractile phenotype predominantly express BKCa and Kv channels which are important in mediating excitation-contraction coupling [18], [22], [25], [40], [41], [42], Conversely, synthetic SMC express IKCa channels that control proliferation and migration of SMCs during vasculogenesis by promoting Ca2+ entry and activation of Ca2+-dependent growth factors [38], [43], [44], [45]. The mixed phenotype of CPASMCs with both contractile and synthetic characteristics may account for the functional expression of BKCa, Kv and IKCa channels. BKCa and Kv channel activity in CPASMCs are important in controlling excitation-contraction coupling under basal and agonist-stimulated conditions as pharmacological modulation of these channels alters CPA tone in the intact vessel and perfused placenta [8], [10], [11]. The physiological significance of IKCa channels in CPASMCs is unexplored. Similarly, whether the existence of this channel in CPASMCs is linked to the synthetic phenotype remains to be confirmed. In addition to a putative role in regulating fetoplacental vascular tone, IKCa channels may play an important role in controlling CPASMC proliferation and placental vasculogenesis throughout gestation. Further studies are required to directly correlate whole-cell K+ currents and the contribution from specific channels with the expression of SMC phenotypic markers.

In conclusion, this study provides the first direct evidence for Kv, BKCa IKCa and SKCa channel currents in CPASMCs. These cells display a mixed phenotype implicating a dual role for CPASMCs in controlling both fetoplacental vascular resistance and vasculogenesis throughout pregnancy.

Acknowledgments

We acknowledge the midwifery staff at St Mary's Hospital, Manchester in particular Linda Peacock for recruitment of the human placental tissue. We thank Dr Peter Brown (University of Manchester, UK) for providing the use of his microelectrode puller and Dr Iain Greenwood (St George's University of London, UK) for help and guidance with the cell isolation procedure.

Author Contributions

Conceived and designed the experiments: MFB MW SLG RLJ. Performed the experiments: MFB. Analyzed the data: MFB. Contributed reagents/materials/analysis tools: MFB SLG MW RLJ. Wrote the paper: MFB.

References

  1. 1. Wareing M, Crocker IP, Warren AY, Taggart MJ, Baker PN (2002) Characterization of small arteries isolated from the human placental chorionic plate. Placenta 23: 400–409.
  2. 2. Maigaard S, Forman A, Andersson KE (1986) Differential effects of angiotensin, vasopressin and oxytocin on various smooth muscle tissues within the human uteroplacental unit. Acta Physiol Scand 128: 23–31.
  3. 3. Myatt L, Brewer A, Brockman DE (1991) The action of nitric oxide in the perfused human fetal-placental circulation. Am J Obstet Gynecol 164: 687–692.
  4. 4. Jackson WF (2000) Ion channels and vascular tone. Hypertension 35: 173–178.
  5. 5. Standen NB, Quayle JM (1998) K+ channel modulation in arterial smooth muscle. Acta Physiol Scand 164: 549–557.
  6. 6. Jewsbury S, Baker PN, Wareing M (2007) Relaxation of human placental arteries and veins by ATP-sensitive potassium channel openers. Eur J Clin Invest 37: 65–72.
  7. 7. Kiernan MF, Barrie A, Szkolar J, Mills TA, Wareing M (2010) Functional evidence for oxygen-sensitive voltage-gated potassium channels in human placental vasculature. Placenta 31: 553–555.
  8. 8. Wareing M, Bai X, Seghier F, Turner CM, Greenwood SL, et al. (2006) Expression and function of potassium channels in the human placental vasculature. Am J Physiol Regul Integr Comp Physiol 291: R437–446.
  9. 9. Wareing M, Greenwood SL, Fyfe GK, Baker PN, Taggart MJ (2006) Glibenclamide inhibits agonist-induced vasoconstriction of placental chorionic plate arteries. Placenta 27: 660–668.
  10. 10. Hampl V, Bibova J, Stranak Z, Wu X, Michelakis ED, et al. (2002) Hypoxic fetoplacental vasoconstriction in humans is mediated by potassium channel inhibition. Am J Physiol Heart Circ Physiol 283: H2440–2449.
  11. 11. Sand A, Andersson E, Fried G (2006) Nitric oxide donors mediate vasodilation in human placental arteries partly through a direct effect on potassium channels. Placenta 27: 181–190.
  12. 12. Wareing M, Greenwood SL (2011) Review: Potassium channels in the human fetoplacental vasculature. Placenta 32 Suppl 2S203–206.
  13. 13. Ibrahim B, Guiet-Bara A, Leveteau J, Bara M (1998) Involvement of external potassium in membrane potential of smooth muscle cells of human allantochorial placental vessels. Bioelectrochemistry and Bioenergetics 48: 131–134.
  14. 14. Guiet-Bara A, Ibrahim B, Leveteau J, Bara M (1999) Calcium channels, potassium channels and membrane potential of smooth muscle cells of human allantochorial placental vessels. Bioelectrochem Bioenerg 48: 407–413.
  15. 15. Corcoran J, Lacey H, Baker PN, Wareing M (2008) Altered potassium channel expression in the human placental vasculature of pregnancies complicated by fetal growth restriction. Hypertens Pregnancy 27: 75–86.
  16. 16. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ (1981) Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch 391: 85–100.
  17. 17. Beech DJ, Bolton TB (1989) Two components of potassium current activated by depolarization of single smooth muscle cells from the rabbit portal vein. J Physiol 418: 293–309.
  18. 18. Clapp LH, Gurney AM (1991) Outward currents in rabbit pulmonary artery cells dissociated with a new technique. Exp Physiol 76: 677–693.
  19. 19. Gollasch M, Ried C, Bychkov R, Luft FC, Haller H (1996) K+ currents in human coronary artery vascular smooth muscle cells. Circ Res 78: 676–688.
  20. 20. Halliday FC, Aaronson PI, Evans AM, Gurney AM (1995) The pharmacological properties of K+ currents from rabbit isolated aortic smooth muscle cells. Br J Pharmacol 116: 3139–3148.
  21. 21. Smirnov SV, Aaronson PI (1992) Ca(2+)-activated and voltage-gated K+ currents in smooth muscle cells isolated from human mesenteric arteries. J Physiol 457: 431–454.
  22. 22. Smirnov SV, Beck R, Tammaro P, Ishii T, Aaronson PI (2002) Electrophysiologically distinct smooth muscle cell subtypes in rat conduit and resistance pulmonary arteries. J Physiol 538: 867–878.
  23. 23. Sones WR, Leblanc N, Greenwood IA (2009) Inhibition of vascular calcium-gated chloride currents by blockers of KCa1.1, but not by modulators of KCa2.1 or KCa2.3 channels. Br J Pharmacol 158: 521–531.
  24. 24. Sweeney M, Jones CJ, Greenwood SL, Baker PN, Taggart MJ (2006) Ultrastructural features of smooth muscle and endothelial cells of isolated isobaric human placental and maternal arteries. Placenta 27: 635–647.
  25. 25. Archer SL, Huang JM, Reeve HL, Hampl V, Tolarova S, et al. (1996) Differential distribution of electrophysiologically distinct myocytes in conduit and resistance arteries determines their response to nitric oxide and hypoxia. Circ Res 78: 431–442.
  26. 26. Owens GK, Kumar MS, Wamhoff BR (2004) Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 84: 767–801.
  27. 27. Sampson U, Brereton MF, Jones RL, Wareing M, Mills TA, et al. (2010) Kv1.5 channel expression in human placental resistance arteries of normal pregnancy and fetal growth restriction.. Proc Physiol Soc 20: PC4.
  28. 28. Mills TA, Shweikh Y, Greenwood SL, Jones RL, Wareing M (2009) Control of human chorionic plate arterial tone: a role for Kv7 channels? Reprod Sci 163A.
  29. 29. Fyfe GK, Panicker S, Jones RL, Wareing M (2012) Expression of an electrically silent voltage-gated potassium channel in the human placenta. J Obstet Gynaecol 32: 624–629.
  30. 30. Edwards G, Dora KA, Gardener MJ, Garland CJ, Weston AH (1998) K+ is an endothelium-derived hyperpolarizing factor in rat arteries. Nature 396: 269–272.
  31. 31. Garland CJ, Hiley CR, Dora KA (2010) EDHF: spreading the influence of the endothelium. Br J Pharmacol
  32. 32. Edwards G, Gardener MJ, Feletou M, Brady G, Vanhoutte PM, et al. (1999) Further investigation of endothelium-derived hyperpolarizing factor (EDHF) in rat hepatic artery: studies using 1-EBIO and ouabain. Br J Pharmacol 128: 1064–1070.
  33. 33. Busse R, Edwards G, Feletou M, Fleming I, Vanhoutte PM, et al. (2002) EDHF: bringing the concepts together. Trends Pharmacol Sci 23: 374–380.
  34. 34. Pedersen KA, Schroder RL, Skaaning-Jensen B, Strobaek D, Olesen SP, et al. (1999) Activation of the human intermediate-conductance Ca(2+)-activated K(+) channel by 1-ethyl-2-benzimidazolinone is strongly Ca(2+)-dependent. Biochim Biophys Acta 1420: 231–240.
  35. 35. Ishii TM, Maylie J, Adelman JP (1997) Determinants of apamin and d-tubocurarine block in SK potassium channels. J Biol Chem 272: 23195–23200.
  36. 36. McNeish AJ, Sandow SL, Neylon CB, Chen MX, Dora KA, et al. (2006) Evidence for involvement of both IKCa and SKCa channels in hyperpolarizing responses of the rat middle cerebral artery. Stroke 37: 1277–1282.
  37. 37. Beech DJ, Cheong A (2006) Potassium channels at the beginnings of cell proliferation. J Physiol 570: 1.
  38. 38. Neylon CB (2002) Potassium channels and vascular proliferation. Vascul Pharmacol 38: 35–41.
  39. 39. Beech DJ (2007) Ion channel switching and activation in smooth-muscle cells of occlusive vascular diseases. Biochem Soc Trans 35: 890–894.
  40. 40. Ko EA, Burg ED, Platoshyn O, Msefya J, Firth AL, et al. (2007) Functional characterization of voltage-gated K+ channels in mouse pulmonary artery smooth muscle cells. Am J Physiol Cell Physiol 293: C928–937.
  41. 41. Platoshyn O, Remillard CV, Fantozzi I, Mandegar M, Sison TT, et al. (2004) Diversity of voltage-dependent K+ channels in human pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 287: L226–238.
  42. 42. Rhodes MT, Porter VA, Saqueton CB, Herron JM, Resnik ER, et al. (2001) Pulmonary vascular response to normoxia and K(Ca) channel activity is developmentally regulated. Am J Physiol Lung Cell Mol Physiol 280: L1250–1257.
  43. 43. Neylon CB, Lang RJ, Fu Y, Bobik A, Reinhart PH (1999) Molecular cloning and characterization of the intermediate-conductance Ca(2+)-activated K(+) channel in vascular smooth muscle: relationship between K(Ca) channel diversity and smooth muscle cell function. Circ Res 85: e33–43.
  44. 44. Reeve HL, Weir EK, Archer SL, Cornfield DN (1998) A maturational shift in pulmonary K+ channels, from Ca2+ sensitive to voltage dependent. Am J Physiol 275: L1019–1025.
  45. 45. Snetkov VA, Pandya H, Hirst SJ, Ward JP (1998) Potassium channels in human fetal airway smooth muscle cells. Pediatr Res 43: 548–554.